Systemic lupus erythematosus risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 11: | Line 11: | ||
* Race: African Americans and Asians are affected more often than people from other races. | * Race: African Americans and Asians are affected more often than people from other races. | ||
* Drugs, such as [[chlorpromazine]], [[hydralazine]], [[isoniazid]], [[methyldopa]], [[penicillamine]], [[procainamide]], [[quinidine]] and [[sulfasalazine]]. | * Drugs, such as [[chlorpromazine]], [[hydralazine]], [[isoniazid]], [[methyldopa]], [[penicillamine]], [[procainamide]], [[quinidine]] and [[sulfasalazine]]. | ||
* People with relatives who suffer from SLE, [[rheumatoid arthritis]] or [[thrombotic thrombocytopenic purpura]] are at a slightly higher risk than the general population.<ref name="DiGeronimo">DiGeronimo, Theresa. New Hope for People with Lupus. Prima Publishing. 2002.</ref> | * People with relatives who suffer from [[SLE]], [[rheumatoid arthritis]] or [[thrombotic thrombocytopenic purpura]] are at a slightly higher risk than the general population.<ref name="DiGeronimo">DiGeronimo, Theresa. New Hope for People with Lupus. Prima Publishing. 2002.</ref> | ||
==References== | ==References== | ||
Revision as of 13:27, 3 August 2012
|
Systemic lupus erythematosus Microchapters |
|
Differentiating Systemic lupus erythematosus from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Systemic lupus erythematosus risk factors On the Web |
|
American Roentgen Ray Society Images of Systemic lupus erythematosus risk factors |
|
Directions to Hospitals Treating Systemic lupus erythematosus |
|
Risk calculators and risk factors for Systemic lupus erythematosus risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Risk Factors
The underlying cause of this autoimmune disease is not clear. Clinical data show the onset of systemic lupus erythematosus is associated with the following factors:
- Female: SLE affects nine times as many women as men.
- Age: From 10 to 50
- Race: African Americans and Asians are affected more often than people from other races.
- Drugs, such as chlorpromazine, hydralazine, isoniazid, methyldopa, penicillamine, procainamide, quinidine and sulfasalazine.
- People with relatives who suffer from SLE, rheumatoid arthritis or thrombotic thrombocytopenic purpura are at a slightly higher risk than the general population.[1]
References
- ↑ DiGeronimo, Theresa. New Hope for People with Lupus. Prima Publishing. 2002.